Now showing items 1-3 of 3
2016 ESC and ACC/AHA/HFSA heart failure guideline updates: Changes, similarities, differences, and unresolved isssues
(TURKISH SOC CARDIOLOGY, 2016)
Heart rate in heart failure with mid-range ejection fraction
(TURKISH SOC CARDIOLOGY, 2019)
In vivo and in vitro evidence for pleiotropic effects of levosimendan in the intensive care setting
(BIOMED CENTRAL LTD, 2011)
Levosimendan, in addition to its inotropic properties, could have anti-inflammatory and anti-oxidative properties, and can potentially decrease the deleterious effects of reactive oxygen species on the tissues. In their ...